PI
SCLN

PineBridge Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

PineBridge Investments’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,477
Closed -$73K – 1208
2017
Q3 		$73K Sell
6,477
-339
-5% -$3.74K ﹤0.01% 1000
2017
Q2 		$75K Buy
6,816
+101
+2% +$1.01K ﹤0.01% 973
2017
Q1 		$66K Buy
6,715
+365
+6% +$3.65K ﹤0.01% 994
2016
Q4 		$68K Hold
6,350
– – ﹤0.01% 1042
2016
Q3 		$65K Buy
6,350
+21
+0.3% +$229 ﹤0.01% 911
2016
Q2 		$82K Buy
+6,329
New +$82.9K ﹤0.01% 841

PineBridge Investments's SCLN Position: Q4 2017 in Review

PineBridge Investments sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 6,477 shares — an estimated $73K sold.

PineBridge Investments first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $82K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • PineBridge Investments reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • PineBridge Investments sold 6,477 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $73K.
  • PineBridge Investments first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • PineBridge Investments's Sciclone Pharmaceuticals Inc position peaked at $82K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on PineBridge Investments's 13F filing for Q4 2017, filed 9 Feb 2018.